ExSAR H/D-Exchange

Small molecule therapeutics for protein-misfolding diseases

As a development-stage company, we’re leveraging our proprietary H/D-Exchange technology to screen lead compounds for their ability to prevent protein misfolding and restore protein function in our quest to identify, develop and commercialize small molecule therapeutics for protein misfolding diseases like Gaucher, Late-Onset Tay Sachs, Sandhoff, ALS and Parkinson’s.